Tuesday, 15 October 2019

Generics News

  • Avanir Pharma settles patent litigation with Wockhardt

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

    Singapore: US based Avanir Pharmaceuticals has entered into a settlement agreement with India's Wockhardt to resolve pending patent litigation in response to Wockhardt's abbreviated new dru...Read more

  • TWi Pharma gets FDA nod for ADHD drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 May, 2013

    Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (ANDA) for Guanfacine Hydrochloride extended release tablets 1mg, 2mg, 3...Read more

  • Sandoz launches trial with Amgen biosimilar

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's Enbrel. With this, Novartis has consolidated its leading position in...Read more

  • US company leverages on generics

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: US based Par Pharmaceutical has entered into agreements with Watson Pharmaceuticals and Actavis Group to purchase for cash five generic products that are currently marketed in th...Read more

  • NATCO wins compulsory license for anti-cancer drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2012

    In a landmark decision, Hyderabad-based NATCO Pharma has been granted compulsory license for Sorafenib Tosylate sold under the brand name of Nexavar owned by Bayer. Nexavar is the first-li...Read more

  • Mylan gets FDA nod for Thiamine Hydrochloride Injection

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Mylan Institutional business has received final approval from the US Food and Drug Administration (FDA) for Mylan's abbreviated new drug application (ANDA) for preservative-free...Read more

  • Big pharma to drive R&D innovation with $4.4 bn

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

    Singapore: The European Commission (EC) and other leading pharma giants have come together to invest $4.4 billion into programs that would be focused on innovation in the health sector over...Read more

  • Multiple organzations join hands to curb fake drug business

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market and has joined hands with 11 new organizations to strengthen its glo...Read more

  • Arvind sets up $42.37 mn plant top tap US market

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company has invested $42.37 million to set up a new manufacturing facility at ...Read more

  • Lilly strengthens its foothold in China

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, June 15, 2012:  In support of its commitment to maximize growth opportunities in China, Eli Lilly has plans to increase its network of manufacturing capabilities in the country ...Read more

  • Cipla gets drug pricing breather from Delhi Court

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not to take coercive steps against pharma major Cipla. The company was tol...Read more

  • Industry body expresses concern over Nexavar decision

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2012

    The Association of Biotechnology Led Enterprises (ABLE), a national forum that represents the $4 billion biotechnology industry in India, reacted sharply to India's grant of a compulsory li...Read more

  • US FDA approves Suprax 400 mg by Lupin

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Mumbai: Lupin Pharmaceuticals, a subsidiary of India-based Lupin, has received approval for Suprax (Cefixime) Capsules 400 mg from the US Food and Drugs Administration (FDA). A statement re...Read more

  • Tiyanyin pharma all set for GMP inspection

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: China-based Tianyin Pharmaceutical is looking ahead to get its Qionglai Facility (QLF) GMP certified post insepction by China Food and Drug Administration (CFDA) expected to begi...Read more

  • Simcere, Zhuhai enter share transfer agreement

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Leading pharmaceutical company, Simcere Pharmaceutical, announced sale of equity interest in Jilin Bodapharmaceutical (Boda). The company entered into a share transfer agreement ...Read more

  • New CoolPal Vertos Advance launched by Pelican BioThermal

    Generics |  News | 0 Comment | 19 Jan, 2017

    US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-controlled packaging solutions serving the life sciences industry has r...Read more

  • CEPI board meeting with a focus on identifying disease priorities and future strategy

    Generics |  News | 0 Comment | 19 Dec, 2016

    The Department of Biotechnology (DBT) will be partnering in the Coalition for Epidemic Preparedness and Innovations (CEPI) which is a new global alliance among governments, industries, acad...Read more



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls